Abcam is a life-science e-commerce company which facilitates public customer feedback on products using reviews and ratings submitted by customers. This has given rise to the nickname "the Amazon of antibodies". Since 2011, through acquisition, the company has moved into direct production of biotechnological products. The company was founded in 1998 by Jonathan Milner with co-founders Professor Tony Kouzarides and David Cleevely, with the idea of making it easier for research scientists to buy antibodies across the web. Milner was a postdoctoral researcher studying the newly discovered breast cancer protein BRCA2 in Kouzarides' Cambridge University laboratory. The project had slowed because of problems finding quality antibody reagents that had honest and up-to-date information about their uses and limitations. This scenario provided the motivation to form an on-line service that would help themselves and researchers across the globe.